Dianthus Therapeutics
DNTH
DNTH
51 hedge funds and large institutions have $162M invested in Dianthus Therapeutics in 2018 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less capital invested
Capital invested by funds: $182M → $162M (-$19.9M)
Holders
51
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.58M | |
| 2 | +$2.1M | |
| 3 | +$1.56M | |
| 4 |
BlackRock
New York
|
+$861K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$834K |
Top Sellers
| 1 | -$1.86M | |
| 2 | -$1.51M | |
| 3 | -$1.17M | |
| 4 |
Goldman Sachs
New York
|
-$1.02M |
| 5 |
Alkeon Capital Management
New York
|
-$918K |